[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  BiopharmIQ by Amp [@BiopharmIQ](/creator/twitter/BiopharmIQ) on x 25.7K followers Created: 2025-07-10 15:53:27 UTC 📢 In case you missed it: Merck $MRK to Acquire Verona Pharma $VRNA 💸 Total transaction value ~$10B ($107 per ADS) 🫁 Deal adds Ohtuvayre, the first novel inhaled COPD treatment in >20 years → approved by FDA in June 2024 → launched August 2024 with rapid U.S. uptake; also in trials for non-CF bronchiectasis ✅ Closing expected Q4 2025 See image for more info 👇 📸  XXXXX engagements  **Related Topics** [$2175m](/topic/$2175m) [holders](/topic/holders) [alternative investment](/topic/alternative-investment) [$4379share](/topic/$4379share) [more info](/topic/more-info) [ads](/topic/ads) [$10b](/topic/$10b) [$vrna](/topic/$vrna) [Post Link](https://x.com/BiopharmIQ/status/1943337784171008459)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
BiopharmIQ by Amp @BiopharmIQ on x 25.7K followers
Created: 2025-07-10 15:53:27 UTC
📢 In case you missed it: Merck $MRK to Acquire Verona Pharma $VRNA
💸 Total transaction value ~$10B ($107 per ADS)
🫁 Deal adds Ohtuvayre, the first novel inhaled COPD treatment in >20 years → approved by FDA in June 2024 → launched August 2024 with rapid U.S. uptake; also in trials for non-CF bronchiectasis
✅ Closing expected Q4 2025
See image for more info 👇 📸
XXXXX engagements
Related Topics $2175m holders alternative investment $4379share more info ads $10b $vrna
/post/tweet::1943337784171008459